Top

Published in:

01-12-2012 | Clinical Article

Introducing a nationwide registry: the Swiss study on aneurysmal subarachnoid haemorrhage (Swiss SOS)

Authors: Bawarjan Schatlo, Christian Fung, Ali-Reza Fathi, Martin Sailer, Kerstin Winkler, Roy Thomas Daniel, Philippe Bijlenga, Peter Ahlborn, Martin Seule, Daniel Zumofen, Michael Reinert, Christoph Woernle, Martin Stienen, Marc Levivier, Gerhard Hildebrandt, Luigi Mariani, René Bernays, Javier Fandino, Andreas Raabe, Emanuela Keller, Karl Schaller

Published in: Acta Neurochirurgica | Issue 12/2012

Abstract

Background

Aneurysmal subarachnoid haemorrhage (aSAH) is a haemorrhagic form of stroke and occurs in a younger population compared with ischaemic stroke or intracerebral haemorrhage. It accounts for a large proportion of productive life-years lost to stroke. Its surgical and medical treatment represents a multidisciplinary effort. Due to the complexity of the disease, the management remains difficult to standardise and quality of care is accordingly difficult to assess.

Objective

To create a registry to assess management parameters of patients treated for aSAH in Switzerland.

Methods

A cohort study was initiated with the aim to record characteristics of patients admitted with aSAH, starting January 1st 2009. Ethical committee approval was obtained or is pending from the institutional review boards of all centres. In the study period, seven Swiss hospitals (five university [U], two non-university medical centres) harbouring a neurosurgery department, an intensive care unit and an interventional neuroradiology team so far agreed to participate in the registry (Aarau, Basel [U], Bern [U], Geneva [U], Lausanne [U], St. Gallen, Zürich [U]). Demographic and clinical parameters are entered into a common database.

Discussion

This database will soon provide (1) a nationwide assessment of the current standard of care and (2) the outcomes for patients suffering from aSAH in Switzerland. Based on data from this registry, we can conduct cohort comparisons or design diagnostic or therapeutic studies on a national level. Moreover, a standardised registration system will allow healthcare providers to assess the quality of care.

Barker FG 2nd, Amin-Hanjani S, Butler WE, Ogilvy CS, Carter BS (2003) In-hospital mortality and morbidity after surgical treatment of unruptured intracranial aneurysms in the United States, 1996–2000: the effect of hospital and surgeon volume. Neurosurgery 52:995–1007, discussion 1007–1009PubMedCrossRef

Barth M, Capelle HH, Weidauer S, Weiss C, Munch E, Thome C, Luecke T, Schmiedek P, Kasuya H, Vajkoczy P (2007) Effect of nicardipine prolonged-release implants on cerebral vasospasm and clinical outcome after severe aneurysmal subarachnoid hemorrhage: a prospective, randomized, double-blind phase IIa study. Stroke 38:330–336PubMedCrossRef

de Rooij NK, Linn FH, van der Plas JA, Algra A, Rinkel GJ (2007) Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends. J Neurol Neurosurg Psychiatry 78:1365–1372PubMedCrossRef

Dodel R, Winter Y, Ringel F, Spottke A, Gharevi N, Muller I, Klockgether T, Schramm J, Urbach H, Meyer B (2010) Cost of illness in subarachnoid hemorrhage: a German longitudinal study. Stroke41:2918–2923PubMedCrossRef

Dorhout Mees SM, Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J (2007) Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev (3):CD000277

Dreier JP (2011) The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease. Nat Med 17:439–447PubMedCrossRef

Fisher CM, Kistler JP, Davis JM (1980) Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6:1–9PubMedCrossRef

Graff-Radford NR, Torner J, Adams HP Jr, Kassell NF (1989) Factors associated with hydrocephalus after subarachnoid hemorrhage. A report of the Cooperative Aneurysm Study. Arch Neurol 46:744–752PubMedCrossRef

Hemphill JC, Andrews P, De Georgia M (2011) Multimodal monitoring and neurocritical care bioinformatics. Nat Rev Neurol 7:451–460PubMedCrossRef

10.

Jaeger M, Soehle M, Schuhmann MU, Winkler D, Meixensberger J (2005) Correlation of continuously monitored regional cerebral blood flow and brain tissue oxygen. Acta Neurochir (Wien) 147:51–56, discussion 56CrossRef

11.

Johnston SC, Selvin S, Gress DR (1998) The burden, trends, and demographics of mortality from subarachnoid hemorrhage. Neurology 50:1413–1418PubMedCrossRef

12.

Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Marr A, Roux S, Kassell N (2011) Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 10:618–625PubMedCrossRef

13.

Macdonald RL, Pluta RM, Zhang JH (2007) Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat Clin Pract Neurol 3:256–263PubMedCrossRef

14.

Maud A, Lakshminarayan K, Suri MF, Vazquez G, Lanzino G, Qureshi AI (2009) Cost-effectiveness analysis of endovascular versus neurosurgical treatment for ruptured intracranial aneurysms in the United States. J Neurosurg 110:880–886PubMedCrossRef

15.

Meyer B, Ringel F, Winter Y, Spottke A, Gharevi N, Dams J, Balzer-Geldsetzer M, Mueller IK, Klockgether T, Schramm J, Urbach H, Dodel R (2010) Health-related quality of life in patients with subarachnoid haemorrhage. Cerebrovasc Dis 30:423–431PubMedCrossRef

16.

Rabinstein AA, Weigand S, Atkinson JL, Wijdicks EF (2005) Patterns of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 36:992–997PubMedCrossRef

17.

Rosen DS, Macdonald RL (2005) Subarachnoid hemorrhage grading scales: a systematic review. Neurocrit Care 2:110–118PubMedCrossRef

18.

Taylor CL, Yuan Z, Selman WR, Ratcheson RA, Rimm AA (1997) Mortality rates, hospital length of stay, and the cost of treating subarachnoid hemorrhage in older patients: institutional and geographical differences. J Neurosurg 86:583–588PubMedCrossRef

19.

Vajkoczy P, Horn P, Thome C, Munch E, Schmiedek P (2003) Regional cerebral blood flow monitoring in the diagnosis of delayed ischemia following aneurysmal subarachnoid hemorrhage. J Neurosurg 98:1227–1234PubMedCrossRef

20.

Wilson JT, Pettigrew LE, Teasdale GM (1998) Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma 15:573–585PubMedCrossRef

21.

Zwienenberg-Lee M, Hartman J, Rudisill N, Madden LK, Smith K, Eskridge J, Newell D, Verweij B, Bullock MR, Baker A, Coplin W, Mericle R, Dai J, Rocke D, Muizelaar JP (2008) Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial. Stroke; J Cereb Circ 39:1759–1765CrossRef

Title: Introducing a nationwide registry: the Swiss study on aneurysmal subarachnoid haemorrhage (Swiss SOS)
Authors: Bawarjan Schatlo
Christian Fung
Ali-Reza Fathi
Martin Sailer
Kerstin Winkler
Roy Thomas Daniel
Philippe Bijlenga
Peter Ahlborn
Martin Seule
Daniel Zumofen
Michael Reinert
Christoph Woernle
Martin Stienen
Marc Levivier
Gerhard Hildebrandt
Luigi Mariani
René Bernays
Javier Fandino
Andreas Raabe
Emanuela Keller
Karl Schaller
Publication date: 01-12-2012
Publisher: Springer Vienna
Published in: Acta Neurochirurgica / Issue 12/2012
Print ISSN: 0001-6268
Electronic ISSN: 0942-0940
DOI: https://doi.org/10.1007/s00701-012-1500-4

At a glance: The STEP trials

Springer Medicine

Introducing a nationwide registry: the Swiss study on aneurysmal subarachnoid haemorrhage (Swiss SOS)

Abstract

Background

Objective

Methods

Discussion

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Objective

Methods

Discussion

Please log in to get access to this content

Other articles of this Issue 12/2012

Historical perspective of carotid artery stenting in Japan: Analysis of 8,092 cases in The Japanese CAS survey

Vagus nerve stimulation in drug-resistant epilepsies. Analysis of potential prognostic factors in a cohort of patients with long-term follow-up

Accreditation of neurosurgical training programmes in Europe: report of the JRAAC

Outer diameter measured by 3D CISS MRI and quasi-Moyamoya disease

On the myth of the Edwin Smith papyrus: is it magic or science?

Outer-diameter narrowing of the internal carotid and middle cerebral arteries in moyamoya disease detected on 3D constructive interference in steady-state MR image: is arterial constrictive remodeling a major pathogenesis?